BVF as of Sept. 30, 2013
Portfolio Holdings for BVF
BVF holds 26 positions in its portfolio as reported in the September 2013 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Ligand Pharmaceuticals In (LGND) | 23.5 | $137M | 3.2M | 43.28 | |
| Ironwood Pharmaceuticals (IRWD) | 16.1 | $94M | 7.9M | 11.85 | |
| Array BioPharma | 10.4 | $61M | 9.7M | 6.22 | |
| Exelixis Inc cnv | 8.3 | $48M | 41M | 1.18 | |
| Rigel Pharmaceuticals | 6.0 | $35M | 9.7M | 3.58 | |
| Targacept | 5.6 | $33M | 6.2M | 5.31 | |
| Chemocentryx | 5.1 | $30M | 5.4M | 5.56 | |
| Oncothyreon | 3.1 | $18M | 8.9M | 2.06 | |
| Exelixis (EXEL) | 2.5 | $15M | 2.5M | 5.82 | |
| Array Biopharma Inc note 3.000% 6/0 | 2.4 | $14M | 12M | 1.14 | |
| Cytokinetics (CYTK) | 2.2 | $13M | 1.7M | 7.59 | |
| Regado Biosciences | 1.9 | $11M | 1.7M | 6.69 | |
| Qlt | 1.9 | $11M | 2.4M | 4.63 | |
| AVANIR Pharmaceuticals | 1.8 | $10M | 2.4M | 4.24 | |
| Receptos | 1.4 | $8.3M | 320k | 25.97 | |
| Mirati Therapeutics | 1.4 | $8.3M | 545k | 15.15 | |
| ArQule | 1.2 | $6.8M | 2.9M | 2.33 | |
| Pain Therapeutics | 1.1 | $6.4M | 2.4M | 2.72 | |
| Oncomed Pharmaceuticals | 1.0 | $6.0M | 392k | 15.31 | |
| Agios Pharmaceuticals (AGIO) | 0.9 | $5.5M | 197k | 27.96 | |
| Palatin Technologies | 0.6 | $3.5M | 5.2M | 0.68 | |
| Sophiris Bio | 0.5 | $2.8M | 600k | 4.68 | |
| Anthera Pharmaceutcls | 0.4 | $2.2M | 560k | 4.02 | |
| Regulus Therapeutics | 0.4 | $2.2M | 234k | 9.43 | |
| Genvec | 0.1 | $617k | 486k | 1.27 | |
| Transcept Pharmaceuticals | 0.1 | $477k | 150k | 3.18 |
